Copying and distributing are prohibited without permission of the publisher

Poland

  • Pharma companies exposed to transfer pricing challenges

    The interaction of Poland’s transfer pricing rules and reimbursement law means the pharmaceutical industry is faced with complex compliance demands, explains Aneta Blazejewska-Gaczynska and Slawomir Buszko of Ernst & Young.


International Correspondents